Loviscol (Carbocisteine) Syrup (120mL)
Cherry Flavor.
Contents
Carbocisteine.
Description
Pediatric Syrup: 100 mg/5 mL Syrup.
These medicines contain the active ingredient Carbocisteine, a mucolytic agent.
Pediatric Syrup: 100 mg/5 mL Syrup.
These medicines contain the active ingredient Carbocisteine, a mucolytic agent.
Excipients/Inactive Ingredients: Capsule: It also contains starch (10 mg) subcomponent and gelatin capsule (may contain allergens like soybeans, sulfur dioxide, sulphites, artificial colorants, latex, lecithin, alcohols and products thereof) which may cause allergic reactions.
Indications/Uses
Pediatric Syrup/Infant Drops: Carbocisteine (Loviscol) is used as adjunctive therapy for chronic disorders of the respiratory tract associated with excessive or viscous mucus, such as chronic bronchitis, chronic obstructive pulmonary disease and otitis media with effusion including glue ear.
Pediatric Syrup/Infant Drops: Carbocisteine (Loviscol) is used as adjunctive therapy for chronic disorders of the respiratory tract associated with excessive or viscous mucus, such as chronic bronchitis, chronic obstructive pulmonary disease and otitis media with effusion including glue ear.
Dosage and Administration
| AGE | DOSE |
| 2 - 5 Years | 5mL (1 teaspoonful) every 6 hrs |
| 6 - 12 Years | 10mL (2 teaspoonful) every 8 hrs |
Follow the recommended dosage or as prescribed by the physician.
Overdosage
In case of accidental overdose, seek medical assistance immediately.
Contraindications
These products are contraindicated in patients with active peptic ulcer and in cases of known hypersensitivity to Carbocisteine or any of the components of the product.
Special Precautions
Taking of multiple antitussive agents with Carbocisteine is not recommended.
Patients with a history of peptic ulceration should be examined prior to carbocisteine administration to exclude the presence of an active ulcer.
Patients with a history of peptic ulceration should be examined prior to carbocisteine administration to exclude the presence of an active ulcer.
Do not exceed recommended daily dose.
Use In Pregnancy & Lactation
Use in Pregnancy: The safety of Carbocisteine for use during pregnancy has not been established. It should not be used in pregnant women unless, in the judgment of the physician, the expected benefits substantially outweigh the potential risk to the fetus.
Adverse Reactions
Pediatric Syrup/Infant Drops: Nausea, diarrhea, gastric discomfort, gastrointestinal bleeding, and skin rash have occasionally occurred.
Pediatric Syrup/Infant Drops: Nausea, diarrhea, gastric discomfort, gastrointestinal bleeding, and skin rash have occasionally occurred.
Drug Interactions
Dilution with syrups containing pholcodine will cause precipitation.
The use of concomitant antitussive agents is not recommended.
In human studies, no interaction has been found between carbocisteine and antibiotics, antihistamines or costicosteroids.
The use of concomitant antitussive agents is not recommended.
In human studies, no interaction has been found between carbocisteine and antibiotics, antihistamines or costicosteroids.
